TrianglePUBLICATIONS · 9028311
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 1997 Feb 1
- First author
- Horning SJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Horning SJ
- type
- Author
- name
- Chao NJ
- type
- Author
- name
- Negrin RS
- type
- Author
- name
- Hoppe RT
- type
- Author
- name
- Long GD
- type
- Author
- name
- Hu WW
- type
- Author
- name
- Wong RM
- type
- Author
- name
- Brown BW
- type
- Author
- name
- Blume KG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Horning SJ
- type
- Author
- name
- Chao NJ
- type
- Author
- name
- Negrin RS
- type
- Author
- name
- Hoppe RT
- type
- Author
- name
- Long GD
- type
- Author
- name
- Hu WW
- type
- Author
- name
- Wong RM
- type
- Author
- name
- Brown BW
- type
- Author
- name
- Blume KG
- type
- Author
- bibliography ids
- nci-bib-130783b7e8992d55ae39adb7
- book metadata
- content sha256
- 7abbec479d0a0d94eb5052091cc9c46a9fb2e81f71545f6ca72445493969bc4c
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:9028311
- immutable id
- pubmed:9028311@7abbec479d0a0d94eb5052091cc9c46a9fb2e81f71545f6ca72445493969bc4c
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 3
- name
- Blood
- nlm unique id
- 7603509
- pages
- 801-13
- volume
- 89
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 9028311
- provenance
- batch id
- 2752791f8cc3526b9192
- provider
- NCBI PubMed ESummary
- record sha256
- d882f60a353992e2cb50afb73593ab34aad2bd3388e2fc9fb021ca2def1cef96
- response sha256
- 8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
- retrieved at
- 2026-09-09T23:45:25.088603+00:00
- publication date
- display
- 1997 Feb 1
- precision
- day
- year
- 1997
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/9028311/
- title
- High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
Preserved source evidence · Not medical advice